Patient Perspective on Small Intestinal Bacterial Overgrowth (SIBO)

Presented by Tina Aswani Omprakash

SIBO- Tina Aswani
About Tina Aswani Omprakash

Tina Aswani Omprakash is a Functional Gastrointestinal and Motility Disorders (FGID) patient and health advocate based in New York City. She has had FGIDs for as long as she can remember and has had numerous surgeries due to her Crohn’s disease.

Tina maintains a blog and advocacy platform called Own Your Crohn’s ( and recently co-founded IBDesis, a community for South Asians living with inflammatory bowel disease (IBD). Her overarching aim is to normalize the rhetoric around digestive ailments in order to help diverse groups of patients own their ailments to live fuller, happier lives.

Via her writing, lobbying, social media advocacy and speaking engagements, she spearheads public health causes, including those proposing research and creating awareness for IBD, life-saving ostomy surgery, gastroparesis, small intestinal bacterial overgrowth (SIBO) and initiatives supporting health equity for women and racial, ethnic and sexual minorities.

Tina is pursuing her master’s degree in Public Health at Mount Sinai’s Icahn School of Medicine. Additionally, she has spoken at many premier gastrointestinal (GI) conferences, does freelance work for non-profits, ostomy manufacturers, pharmaceutical and digital health companies. Her aim is to help companies recognize disparities and unmet needs in minority health populations.

The Crohn’s & Colitis Foundation recognized Tina in 2021 for her phenomenal leadership and powerful impact on the IBD community with the Above & Beyond Volunteer Award. Tina’s blog was also recognized as a 2020 Best Blog by Healthline and she was awarded the 2019 Healio Gastroenterology Disruptive Innovator Award by the American College of Gastroenterology for moving the needle on GI care for patients.

Share this page
Topics of this article
Was this article helpful?

IFFGD is a nonprofit education and research organization. Our mission is to inform, assist, and support people affected by gastrointestinal disorders.

Our original content is authored specifically for IFFGD readers, in response to your questions and concerns.

If you found this article helpful, please consider supporting IFFGD with a small tax-deductible donation.

Related Information
Personal Stories
Skip to content